The complementarity-determining region-like loops of CD8α interact differently with β2-microglobulin of the class I molecules H-2Kb and thymic leukemia antigen, while similarly with their α3 domains
被引:28
作者:
Devine, L
论文数: 0引用数: 0
h-index: 0
机构:Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
Devine, L
Rogozinski, L
论文数: 0引用数: 0
h-index: 0
机构:Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
Rogozinski, L
Naidenko, OV
论文数: 0引用数: 0
h-index: 0
机构:Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
Naidenko, OV
Cheroutre, H
论文数: 0引用数: 0
h-index: 0
机构:Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
Cheroutre, H
Kavathas, PB
论文数: 0引用数: 0
h-index: 0
机构:Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
Kavathas, PB
机构:
[1] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[3] La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA
The murine CD8 glycoprotein interacts with both classical MHC class I molecules and some nonclassical molecules, including the thymic leukemia Ag (TL). TL binds preferentially to CD8alphaalpha homodimers with a 10-fold higher affinity than H-2K(b) class I molecules. To understand the molecular basis for this difference, we created a panel of CD8alpha mutants and tested the ability of the CD8aa homodimers to bind to H-2K(b) tetramers and TL tetramers. Mutations in three CD8 residues located on the complementarity-determining region-like loops contacting the negatively charged loop in the alpha3 domain of MHC class I greatly reduced binding to both tetramers. Because TL and H-2K(b) class I sequences are highly conserved in the a3 domain of MHC class 1, this suggests that CD8 contacts the alpha3 domain of TL and H-2K(b) in a similar manner. In contrast, mutations in residues on the A and B beta strands of CD8 that are involved in contact with beta(2)-microglobulin affected interaction with the H-2K(b) tetramer, but not the TL tetramer. Therefore, the orientation of interaction of TL with CD8 appears to be different from that of H-2K(b). The unique high affinity binding of TL with CD8alphaalpha is most likely a result of amino acid differences in the alpha3 domain between TL and H-2K(b), particularly at positions 198 (K to D) and 228 (M to T), which are contact residues in the CD8alphaalpha-H-2K(b) cocrystal.
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Gao, GF
;
Willcox, BE
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Willcox, BE
;
Wyer, JR
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Wyer, JR
;
Boulter, JM
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Boulter, JM
;
O'Callaghan, CA
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
O'Callaghan, CA
;
Maenaka, K
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Maenaka, K
;
Stuart, DI
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Stuart, DI
;
Jones, EY
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Jones, EY
;
Van Der Merwe, PA
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Van Der Merwe, PA
;
Bell, JI
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Bell, JI
;
Jakobsen, BK
论文数: 0引用数: 0
h-index: 0
机构:
John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, EnglandJohn Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Gao, GF
;
Willcox, BE
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Willcox, BE
;
Wyer, JR
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Wyer, JR
;
Boulter, JM
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Boulter, JM
;
O'Callaghan, CA
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
O'Callaghan, CA
;
Maenaka, K
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Maenaka, K
;
Stuart, DI
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Stuart, DI
;
Jones, EY
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Jones, EY
;
Van Der Merwe, PA
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Van Der Merwe, PA
;
Bell, JI
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England
Bell, JI
;
Jakobsen, BK
论文数: 0引用数: 0
h-index: 0
机构:
John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, EnglandJohn Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England